home / stock / jbio / jbio news

JBIO News and Press, Jade Biosciences Inc. From 06/02/25

Stock Information
Company Name: Jade Biosciences Inc.
Stock Symbol: JBIO
Market: NASDAQ
Website: jadebiosciences.com/
Menu
JBIO JBIO Quote JBIO Short JBIO News JBIO Articles JBIO Message Board
Get JBIO Alerts

News, Short Squeeze, Breakout and More Instantly...
JBIO - Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress

SAN FRANCISCO and VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced new preclinical data on JADE101, its anti-A...
JBIO - Jade Biosciences, Inc. reports Q1 results

2025-05-15 10:32:05 ET More on Jade Biosciences, Inc. Historical earnings data for Jade Biosciences, Inc. Dividend scorecard for Jade Biosciences, Inc. Financial information for Jade Biosciences, Inc. Read the full article on Seeking Alpha For further...

JBIO - Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update

Completed reverse merger and commenced trading on Nasdaq as JBIO Closed financing, raising approximately $300 million to date, providing cash runway through 2027 Lead candidate JADE101 expected to enter the clinic in second half of 2025, with interim biomarker-rich data ex...

JBIO - Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference

SAN FRANCISCO and VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its participation in the Jefferies Global H...
Previous 10 Next 10